Clinical Trial Update: A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of GSK1363089 in subjects with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GSK1363089 (GSK1363089)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED